Lachesis completes RMB150m B+ round of financing

Lachesis recently announced that it has received 150 million yuan in the B + round of financing. The investors are Shenzhen Capital Group Company and GTJA Investment Group. It is worth noting that this is also the first financing event in the field of smart healthcare in 2020.

Lachesis recently announced that it has received 150 million yuan in the B + round of financing. The investors are Shenzhen Capital Group Company and GTJA Investment Group. It is worth noting that this is also the first financing event in the field of smart healthcare in 2020.

Lachesis is a smart medical overall solution provider, relying on ICT technology and Internet technology to create a “Yihutong” (medical interoperability)platform, providing mobile medical intelligent hardware, application software and mobile clinical overall solutions for hospitals, doctors, and nurses.

Its products cover various fields such as mobile care, intelligent medication, in-hospital instant messaging, equipment management, and vital sign collection.

Lachesis is currently the only company in the smart medical field that can provide integrated software and hardware solutions, and most of its products are independently developed.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/06/03/lachesis-completes-rmb150m-b-round-of-financing/.

Leave a Reply

Please Login to Comment